Bioelectronics Corp (BIEL)

[markjohn62]

I have to disagree with that. Each approved indication has it's own merit. BIEL could be profitable with just the knee or foot indication, not to mention the massive opportunity in RecoveryRX. Dr. Scholls just taking over the foot indication would have given us the legitimacy we are so sorely lacking. The complete lack of any follow through is the issue, not lacking the full clearance for musculoskeletal pain. IMO of course.